OA12845A - Single dose azithromycin for treating respiratory infections. - Google Patents

Single dose azithromycin for treating respiratory infections. Download PDF

Info

Publication number
OA12845A
OA12845A OA1200400048A OA1200400048A OA12845A OA 12845 A OA12845 A OA 12845A OA 1200400048 A OA1200400048 A OA 1200400048A OA 1200400048 A OA1200400048 A OA 1200400048A OA 12845 A OA12845 A OA 12845A
Authority
OA
OAPI
Prior art keywords
dose
pharmaceutical composition
azithromycin
single dose
human
Prior art date
Application number
OA1200400048A
Other languages
English (en)
Inventor
Michael William Dunne
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA12845A publication Critical patent/OA12845A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
OA1200400048A 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections. OA12845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21

Publications (1)

Publication Number Publication Date
OA12845A true OA12845A (en) 2006-09-15

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200400048A OA12845A (en) 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections.

Country Status (25)

Country Link
US (3) US20030148964A1 (es)
EP (1) EP1418924A2 (es)
JP (1) JP2005501862A (es)
KR (1) KR20040032942A (es)
AP (1) AP1729A (es)
BG (1) BG108537A (es)
BR (1) BR0211830A (es)
CA (1) CA2458135A1 (es)
CZ (1) CZ2004232A3 (es)
EA (1) EA200400214A1 (es)
EC (1) ECSP044985A (es)
GE (1) GEP20063812B (es)
HR (1) HRP20040163A2 (es)
HU (1) HUP0401332A2 (es)
IL (1) IL159585A0 (es)
IS (1) IS7092A (es)
MA (1) MA27059A1 (es)
MX (1) MXPA04001605A (es)
OA (1) OA12845A (es)
PL (1) PL367888A1 (es)
SK (1) SK1012004A3 (es)
TN (1) TNSN04035A1 (es)
WO (1) WO2003018031A2 (es)
YU (1) YU8804A (es)
ZA (1) ZA200400804B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572773B2 (en) * 2003-07-24 2009-08-11 Pliva Hrvatska D.O.O. Single dose fast dissolving azithromycin
EP1691787B1 (en) 2003-12-04 2008-07-02 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based preparations of antinfectants for the treatment of lung infections
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
US20110105421A1 (en) * 2008-03-14 2011-05-05 The Florida International University Board Of Trustees Ellagitannins as inhibitors of bacterial quorum sensing
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
BR112015012351A8 (pt) 2012-11-29 2019-10-01 Insmed Inc composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
EP4103725A4 (en) * 2020-02-14 2024-03-27 Asklepios Biopharmaceutical, Inc. METHOD FOR TREATING GENE THERAPY-ASSOCIATED TOXICITY WITH ANTIBIOTICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
UA27040C2 (uk) * 1987-07-09 2000-02-28 Пфайзер Інк. Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (es) * 1992-07-30 1996-03-01 Pfizer
ATE154806T1 (de) * 1993-05-19 1997-07-15 Pfizer Zwischenprodukt für azithromycin
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
JP2977907B2 (ja) * 1994-05-06 1999-11-15 ファイザー・インコーポレーテッド アジスロマイシンの放出調節された剤形
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
US20050250712A1 (en) 2005-11-10
US7067493B2 (en) 2006-06-27
US20030148964A1 (en) 2003-08-07
MA27059A1 (fr) 2004-12-20
AP1729A (en) 2007-03-26
PL367888A1 (en) 2005-03-07
US20040023898A1 (en) 2004-02-05
IS7092A (is) 2003-12-23
CA2458135A1 (en) 2003-03-06
MXPA04001605A (es) 2004-07-08
TNSN04035A1 (fr) 2006-06-01
HUP0401332A2 (hu) 2004-11-29
CZ2004232A3 (cs) 2005-10-12
IL159585A0 (en) 2004-06-01
HRP20040163A2 (en) 2005-02-28
WO2003018031A3 (en) 2003-10-02
AP2004002968A0 (en) 2004-03-31
EA200400214A1 (ru) 2004-06-24
EP1418924A2 (en) 2004-05-19
KR20040032942A (ko) 2004-04-17
ZA200400804B (en) 2005-05-03
JP2005501862A (ja) 2005-01-20
BR0211830A (pt) 2004-09-08
SK1012004A3 (sk) 2005-04-01
US6987093B2 (en) 2006-01-17
WO2003018031A2 (en) 2003-03-06
GEP20063812B (en) 2006-05-10
ECSP044985A (es) 2004-04-28
YU8804A (sh) 2006-08-17
BG108537A (bg) 2005-02-28

Similar Documents

Publication Publication Date Title
Barry et al. Intravenous immunoglobulin therapy for toxic shock syndrome
OA12845A (en) Single dose azithromycin for treating respiratory infections.
US20080089942A1 (en) Use of adsorbent carbon microspheres to treat intestinal bacterial infections
JP2010511039A5 (es)
JP2002523437A5 (es)
Dunne et al. A phase 1 study to assess the pharmacokinetics of sulopenem etzadroxil (PF-03709270)
Marchi Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis
US20060210483A1 (en) Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
Kavi et al. A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin
US20060142254A1 (en) Antipyretic preparation containing xylitol
AU2002313574A1 (en) Single dose azithromycin for treating respiratory infections
CN114375200A (zh) 治疗传染病的药物和方法
Kafetzis et al. Efficacy and safety of roxithromycin in treating paediatric patients. A European multicentre study
Randolph Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis
AkŞÍT et al. Seasonal benzathine penicillin G prophylaxis for recurrent streptococcal pharyngitis in children
RU2498803C1 (ru) Противотуберкулезное лекарственное средство
RU2235543C1 (ru) Способ повышения неспецифической резистентности организма
CA2120917A1 (en) External preparation for treating hemorrhoidal diseases
US20060057133A1 (en) Topical pathogenic-tissue-destroying liquid
Fiese Therapy of coccidioidomycosis
RU2180532C2 (ru) Способ лечения папилломатоза
CA2199255A1 (en) Enteral vaccine for vaginal infections
RU2189811C2 (ru) Способ профилактики и лечения респираторных болезней телят
DuPont Overview of clinical experience of pefloxacin in gastrointestinal infections
CA2407724A1 (en) Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal